- About company
- About project
HemaCore is a biotech company, develops medical devices and methods for hematology. HemaCore was founded in April, 2010 by a group of scientist who invented and patented the Thrombodynamics – a new global assay for monitoring and prognosis of blood coagulation disorders: bleeding and thrombosis, precursors of heart attacks and strokes. In 2010 HemaCore received the first round of investments from RUSNANO and Sberbank Capital intended for developing the analyser, consumables and organization of clinical trials in Russia. HemaCore has completed final design of product for the serial production of the Thrombodynamics analyzer and disposables. In Europe and USA: Research Use Only.
Press center
-
25 November 2014 Company news
VEB Innovations Fund invested 60 million rubles into HemaCore Labs
-
29 May 2014 Company news
Research team of HemaCore took part in the International symposium in The Hague
- 13 January 2014 Company news